Harbor Capital Advisors, Inc. Agios Pharmaceuticals, Inc. Transaction History
Harbor Capital Advisors, Inc.
- $2.29 Billion
- Q4 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 33,767 shares of AGIO stock, worth $1.15 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
33,767
Previous 39,090
13.62%
Holding current value
$1.15 Million
Previous $1.74 Million
36.1%
% of portfolio
0.05%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding AGIO
# of Institutions
232Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$193 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$189 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$165 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$127 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$96.5 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.87B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...